- Home
- URGN vs SAFE Comparison
URGN vs SAFE Comparison
Compare URGN & SAFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | URGN | SAFE |
|---|---|---|
| Founded | 2004 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.1B |
| IPO Year | 2016 | 1999 |
Fundamental Metrics
Financial Performance| Metric | URGN | SAFE |
|---|---|---|
| Price | $34.14 | $16.36 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 10 |
| Target Price | ★ $29.29 | $19.00 |
| AVG Volume (30 Days) | ★ 591.6K | 334.2K |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 4.48% |
| EPS Growth | N/A | ★ 7.43 |
| EPS | N/A | ★ 0.40 |
| Revenue | $1,128,000.00 | ★ $385,552,000.00 |
| Revenue This Year | $129.09 | N/A |
| Revenue Next Year | $70.96 | $4.31 |
| P/E Ratio | ★ N/A | $39.23 |
| Revenue Growth | N/A | ★ 5.43 |
| 52 Week Low | $12.73 | $12.76 |
| 52 Week High | $36.08 | $17.16 |
Technical Indicators
Market Signals| Indicator | URGN | SAFE |
|---|---|---|
| Relative Strength Index (RSI) | 66.37 | 62.63 |
| Support Level | $18.58 | $14.88 |
| Resistance Level | N/A | $16.39 |
| Average True Range (ATR) | 1.63 | 0.49 |
| MACD | 0.36 | 0.04 |
| Stochastic Oscillator | 76.37 | 95.78 |
Price Performance
Historical ComparisonAbout URGN UroGen Pharma Ltd.
UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing drugs by enabling sustained release. The company's flagship product, Jelmyto (mitomycin) for pyelocalyceal solution, along with Zusduri (mitomycin) for intravesical solution, targets non-surgical tumor ablation in forms of non-muscle invasive urothelial cancer. The revenue source for the company comes from sales of the Company's approved products, Jelmyto and Zusduri, principally conducted in the United States.
About SAFE Safehold Inc. New
Safehold Inc is a REIT that operates its business by acquiring, managing, and capitalizing ground leases. Ground leases are long-term contracts between the landlord (the Company) and a tenant or leaseholder. Ground leases generally represent ownership of the land underlying commercial real estate projects that are net leased by the fee owner of the land to the owners/operators of the real estate projects built thereon.